# How Manas AI uses Causaly

As published on [causaly.com](https://www.causaly.com/case-studies/how-manas-ai-uses-causaly-to-validate-targets-and-reduce-early-stage-risk), June 2026. Captured by usedby on 2026-10-08.

- Company: [Manas AI](https://www.usedby.ai/companies/manas-ai.md)
- Tool: [Causaly](https://www.usedby.ai/tools/causaly.md)

## What the story says

Manas AI uses Causaly as its primary platform for target identification and validation in drug discovery, running evidence assessments across human genetics, preclinical, clinical, competitor and safety data before committing resources to a target. It also uses the platform as a sanity check at later pipeline stages.

Summary written by usedby from the source page, in English. The figures are those of Causaly and Manas AI, not ours.

> Manas AI uses Causaly as its primary platform for target identification and validation. When a candidate target is identified, whether starting from a disease pathway or from a protein family with known druggability, the team uses Causaly to run a comprehensive evidence assessment before committing resources.

> Companies live and die based on the identification and veracity of their targets. If you make a mistake at the very first step, every step that follows will be a snowball effect from that initial wrong decision.
>
> Dr. Siddhartha Mukherjee, Co-founder, Manas AI

## What usedby checked

We compared the story with its live page on 2026-10-08.

- Checked: the passage quoted above is copied word for word from the page, near the name of Manas AI.
- Checked: the publication date is read from the page’s own metadata, never guessed.
- Checked: Manas AI uses Causaly. Confirmed line. Latest check across sources: 2026-10-08.
- Not checked: the result itself. We quote it; we did not measure it.

---
Source: https://www.usedby.ai/case-studies/manas-ai-causaly · How we check: https://www.usedby.ai/methodology